Google Übersetzer
Royalty Pharma Plc
About
Royalty Pharma Plc (NASDAQ:RPRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
Apr 17 2026
Royalty Pharma Declares Second Quarter 2026 Dividend
Apr 15 2026
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Mar 30 2026
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
Mar 27 2026
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
Financials
Revenue
$2.38 B
Market Cap
$28.09 B
P/E Ratio
27.29
EPS
1.78
Dividend Yield
1.81%